Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Arctic Bioscience AS ( (DE:9TD) ) has provided an announcement.
Arctic Bioscience has completed a share capital increase through the exercise of debt conversion rights, raising its share capital to NOK 2,668,934. This move, which has been registered with the Norwegian Register of Business Enterprises, strengthens the company’s financial position and aligns with disclosure requirements under the Norwegian Securities Act.
More about Arctic Bioscience AS
Arctic Bioscience is a biotech company that focuses on developing and commercializing pharmaceutical and nutraceutical products derived from unique bioactive marine compounds. The company is notably working on HRO350, an innovative oral drug candidate for treating mild-to-moderate psoriasis, and sells nutraceuticals globally under the ROMEGA® brand.
YTD Price Performance: 52.31%
Average Trading Volume: 1,500
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €7.17M
For detailed information about 9TD stock, go to TipRanks’ Stock Analysis page.
